Details for New Drug Application (NDA): 021598
✉ Email this page to a colleague
The generic ingredient in VIGAMOX is moxifloxacin hydrochloride. There are eighteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the moxifloxacin hydrochloride profile page.
Summary for 021598
Tradename: | VIGAMOX |
Applicant: | Harrow Eye |
Ingredient: | moxifloxacin hydrochloride |
Patents: | 0 |
Suppliers and Packaging for NDA: 021598
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VIGAMOX | moxifloxacin hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021598 | NDA | Novartis Pharmaceuticals Corporation | 0078-0939 | 0078-0939-26 | 1 BOTTLE in 1 CARTON (0078-0939-26) / 3 mL in 1 BOTTLE |
VIGAMOX | moxifloxacin hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021598 | NDA AUTHORIZED GENERIC | Sandoz Inc | 0781-7135 | 0781-7135-93 | 1 BOTTLE, PLASTIC in 1 CARTON (0781-7135-93) / 3 mL in 1 BOTTLE, PLASTIC |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 0.5% BASE | ||||
Approval Date: | Apr 15, 2003 | TE: | AT1 | RLD: | Yes |
Expired US Patents for NDA 021598
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Harrow Eye | VIGAMOX | moxifloxacin hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021598-001 | Apr 15, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Harrow Eye | VIGAMOX | moxifloxacin hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021598-001 | Apr 15, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Harrow Eye | VIGAMOX | moxifloxacin hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021598-001 | Apr 15, 2003 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription